Market Overview:
The global hemoglobin analyzer market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of anemia, rising demand for point-of-care testing, and technological advancements in hemoglobin analyzers. Based on type, the global hemoglobin analyzer market is segmented into full-automatic and semi-automatic hemoglobin analyzers. The full-automatic segment is expected to account for a larger share of the global market than the semi-automatic segment during the forecast period. This can be attributed to factors such as ease of use and accuracy offered by full-automatic hemoglobin analyzers over semi-automatic ones. Based on application, the global hematology instruments market is divided into home care, hospitals & clinics, and others (laboratories & research institutes). The hospitals & clinics segment accounted for a larger share of this market than other segments in 2017 and is projected to maintain its dominance during the forecast period owing to rising demand for hematology instruments from these end users across regions.
Product Definition:
A hemoglobin analyzer is a medical device used to measure the amount of hemoglobin in a patient's blood. Hemoglobin is a protein found in red blood cells that carries oxygen throughout the body. Low levels of hemoglobin can indicate anemia, which can cause symptoms such as fatigue and shortness of breath. High levels of hemoglobin can indicate dehydration or congestive heart failure. Hemoglobin levels are often monitored as part of routine blood work to help diagnose and monitor these conditions.
Full-Automatic:
Full-automatic is a technique used in hematology analyzers to measure the hemoglobin level in human blood. It is also known as auto-analyzer or self-contained system. The major advantage of this technique over manual analysis is that it reduces the possibility of operator error and provides more reliable results.
This technology has been around for decades, but its applications were limited to expensive clinical labs with high requirements for accuracy and precision.
Semi-Automatic:
Semi-automatic is a device that analyzes blood without operator intervention. It's an automated system which requires minimal human input and can be used for testing of hemoglobin levels in patients with sickle cell disease, thalassemia or other blood disorders.
The major advantage of using semi-automatic systems over fully automatic systems is the former does not require any extensive training to operate and also provides faster results.
Application Insights:
The home care segment dominated the global market in 2017. The growing geriatric population across the world is expected to be one of the major factors driving this industry. As per a United Nations (UN) study, it was estimated that there would be more than 1 billion people aged 60 or above by 2050, globally. This factor is projected to increase demand for oxygenators over the forecast period which will fuel product demand at a significant rate.
Hospitals and clinics are anticipated to emerge as one of the fastest-growing segments over the forecast period owing to rising awareness regarding better healthcare facilities coupled with an increasing number of patients suffering from blood disorders such as anemia and thrombocytopenia in hospitals and clinics around the globe.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high awareness levels coupled with relatively higher healthcare expenditure in this region. Moreover, increasing R&D activities for improving diagnostic techniques is expected to drive the North American market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising disposable income and growing target population base especially in India and China. In addition, government initiatives for creating awareness regarding blood disorders are likely to propel regional growth over next eight years. ‘Hemoglobin S/C’ or ‘HbS’ condition was first reported from China which led it being named as Asia-Pacific Hb analyzer market leader followed by North America owing its prevalence rate as compared hto other regions across countries such as U.S., Japan & Australia among others).
Growth Factors:
- Increasing prevalence of anemia: The increasing prevalence of anemia is one of the key growth drivers for the hemoglobin analyzer market. According to a study by the World Health Organization (WHO), around 30% of the world’s population suffers from some form of anemia. This number is expected to increase in the coming years due to various factors such as malnutrition, unhealthy diet, and lack of exercise.
- Rising demand for point-of-care testing: Hemoglobin analyzers are increasingly being used for point-of-care testing (POCT). POCT helps in providing results within minutes, which is helpful in making timely and appropriate decisions regarding patient care. This has led to a rise in demand for hemoglobin analyzers worldwide.
- Technological advancements: The hemoglobin analyzer market is witnessing rapid technological advancements, with new products being launched regularly with advanced features and capabilities. This has helped boost sales and adoption rates among end users worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemoglobin Analyzer Market Research Report
By Type
Full-Automatic, Semi-Automatic
By Application
Home Care, Hospitals & Clinics, Others
By Companies
Abbott Laboratories, Alere, Danaher, EKF Diagnostics Holdings, F. Hoffmann-La Roche, Erba diagnostics Mannheim, I-Sens Inc., Infopia Co Ltd, Roche Holding AG, Trinity Biotech, Ceragem Medisys, Convergent Technologies, Drew Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hemoglobin Analyzer Market Report Segments:
The global Hemoglobin Analyzer market is segmented on the basis of:
Types
Full-Automatic, Semi-Automatic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Home Care, Hospitals & Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Alere
- Danaher
- EKF Diagnostics Holdings
- F. Hoffmann-La Roche
- Erba diagnostics Mannheim
- I-Sens Inc.
- Infopia Co Ltd
- Roche Holding AG
- Trinity Biotech
- Ceragem Medisys
- Convergent Technologies
- Drew Scientific
Highlights of The Hemoglobin Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Full-Automatic
- Semi-Automatic
- By Application:
- Home Care
- Hospitals & Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemoglobin Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A hemoglobin analyzer is a medical device that measures the amount of hemoglobin in a blood sample. Hemoglobin is an important protein in the blood, and its level can indicate how well the body's oxygen-carrying system is working. A high level of hemoglobin may indicate anemia, while a low level may be indicative of illness or injury.
Some of the major players in the hemoglobin analyzer market are Abbott Laboratories, Alere, Danaher, EKF Diagnostics Holdings, F. Hoffmann-La Roche, Erba diagnostics Mannheim, I-Sens Inc., Infopia Co Ltd, Roche Holding AG, Trinity Biotech, Ceragem Medisys, Convergent Technologies, Drew Scientific.
The hemoglobin analyzer market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemoglobin Analyzer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemoglobin Analyzer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemoglobin Analyzer Market - Supply Chain
4.5. Global Hemoglobin Analyzer Market Forecast
4.5.1. Hemoglobin Analyzer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemoglobin Analyzer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemoglobin Analyzer Market Absolute $ Opportunity
5. Global Hemoglobin Analyzer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemoglobin Analyzer Market Size and Volume Forecast by Type
5.3.1. Full-Automatic
5.3.2. Semi-Automatic
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemoglobin Analyzer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemoglobin Analyzer Market Size and Volume Forecast by Application
6.3.1. Home Care
6.3.2. Hospitals & Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemoglobin Analyzer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemoglobin Analyzer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemoglobin Analyzer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemoglobin Analyzer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemoglobin Analyzer Demand Share Forecast, 2019-2026
9. North America Hemoglobin Analyzer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemoglobin Analyzer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemoglobin Analyzer Market Size and Volume Forecast by Application
9.4.1. Home Care
9.4.2. Hospitals & Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemoglobin Analyzer Market Size and Volume Forecast by Type
9.7.1. Full-Automatic
9.7.2. Semi-Automatic
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemoglobin Analyzer Demand Share Forecast, 2019-2026
10. Latin America Hemoglobin Analyzer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemoglobin Analyzer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemoglobin Analyzer Market Size and Volume Forecast by Application
10.4.1. Home Care
10.4.2. Hospitals & Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemoglobin Analyzer Market Size and Volume Forecast by Type
10.7.1. Full-Automatic
10.7.2. Semi-Automatic
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemoglobin Analyzer Demand Share Forecast, 2019-2026
11. Europe Hemoglobin Analyzer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemoglobin Analyzer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemoglobin Analyzer Market Size and Volume Forecast by Application
11.4.1. Home Care
11.4.2. Hospitals & Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemoglobin Analyzer Market Size and Volume Forecast by Type
11.7.1. Full-Automatic
11.7.2. Semi-Automatic
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential nalysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemoglobin Analyzer Demand Share, 2019-2026
12. Asia Pacific Hemoglobin Analyzer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemoglobin Analyzer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemoglobin Analyzer Market Size and Volume Forecast by Application
12.4.1. Home Care
12.4.2. Hospitals & Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemoglobin Analyzer Market Size and Volume Forecast by Type
12.7.1. Full-Automatic
12.7.2. Semi-Automatic
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemoglobin Analyzer Demand Share, 2019-2026
13. Middle East & Africa Hemoglobin Analyzer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemoglobin Analyzer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemoglobin Analyzer Market Size and Volume Forecast by Application
13.4.1. Home Care
13.4.2. Hospitals & Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemoglobin Analyzer Market Size and Volume Forecast by Type
13.7.1. Full-Automatic
13.7.2. Semi-Automatic
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemoglobin Analyzer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemoglobin Analyzer Market: Market Share Analysis
14.2. Hemoglobin Analyzer Distributors and Customers
14.3. Hemoglobin Analyzer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alere
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. EKF Diagnostics Holdings
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. F. Hoffmann-La Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Erba diagnostics Mannheim
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. I-Sens Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Infopia Co Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Roche Holding AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Trinity Biotech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ceragem Medisys
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Convergent Technologies
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Drew Scientific
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
